"**Atherosclerosis Market Size And Forecast by 2031**

Data Bridge Market Research analyses that the Global Atherosclerosis Market which was USD 2.55 Billion in 2021 is expected to reach USD 4.11 Billion by 2029 and is expected to undergo a CAGR of 6.16% during the forecast period of 2021 to 2029

Atherosclerosis Market research report provides a comprehensive analysis of the market. The report aims to provide insights into Atherosclerosis Market trends, growth opportunities, key drivers and challenges, competitive landscape, and other crucial factors that may impact the market in the forecast period (2024-2031).

Get a Sample PDF of Report - https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-atherosclerosis-market

Which are the top companies operating in the Atherosclerosis Market?

The study report on the Global Atherosclerosis Market offers a comprehensive analysis of the industry, highlighting key trends, market dynamics, and competitive landscape. It profiles prominent organizations operating in the market, examining their successful strategies and market share contributions. This Atherosclerosis Market report provides the information of the Top 10 Companies in Atherosclerosis Market in the market their business strategy, financial situation etc.

• Segments*

The global atherosclerosis market can be segmented based on type, treatment, and end-user. In terms of type, the market can be categorized into coronary atherosclerosis, carotid atherosclerosis, peripheral arterial disease, and others. Coronary atherosclerosis is a significant segment due to the high prevalence of coronary artery disease worldwide. Carotid atherosclerosis, affecting the arteries in the neck, is also a crucial segment as it can lead to stroke if left untreated. Peripheral arterial disease, which impacts the arteries in the limbs, is another key segment in the market. In terms of treatment, the market can be divided into medication, surgery, and others. Medications such as statins, antiplatelet drugs, and anticoagulants play a vital role in managing atherosclerosis. Surgical interventions like angioplasty, stenting, and bypass surgery are essential for severe cases. The end-user segment includes hospitals, clinics, ambulatory surgical centers, and others, with hospitals being the primary end-user due to the availability of advanced treatment facilities.

• Market Players*
• Pfizer Inc.
• AstraZeneca
• Sanofi
• Merck & Co., Inc.
• Novartis AG
• Amgen Inc.
• Bristol-Myers Squibb Company
• Abbott
• GlaxoSmithKline plc
• Johnson & Johnson Services, Inc.

The global atherosclerosis market is witnessing significant growth due to several factors. One of the key drivers is the increasing prevalence of lifestyle-related diseases such as obesity, hypertension, and diabetes, which are major risk factors for atherosclerosis. The aging population worldwide is also contributing to the rise in atherosclerosis cases, as the condition is more common in older individuals. Moreover, advancements in diagnostic technologies such as imaging techniques and biomarker testing have improved the early detection of atherosclerosis, leading to timely intervention and better outcomes for patients.